1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. HIV or AIDS Diagnostics Market, by Product Type
6.1. Introduction
6.2. Instruments
6.3. Kits & Reagents

7. HIV or AIDS Diagnostics Market, by Test Type
7.1. Introduction
7.2. ELISA
7.3. Nucleic Acid Tests
7.4. Rapid Tests

8. HIV or AIDS Diagnostics Market, by End User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Hospitals
8.4. Private Diagnostics Laboratories

9. California HIV or AIDS Diagnostics Market

10. Florida HIV or AIDS Diagnostics Market

11. Illinois HIV or AIDS Diagnostics Market

12. New York HIV or AIDS Diagnostics Market

13. Ohio HIV or AIDS Diagnostics Market

14. Pennsylvania HIV or AIDS Diagnostics Market

15. Texas HIV or AIDS Diagnostics Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Abbott Laboratories
17.2. Alere Inc.
17.3. Becton Dickinson and Company
17.4. Bio-Rad Laboratories, Inc.
17.5. Chembio Diagnostic Systems Inc.
17.6. Danaher Corporation
17.7. F. Hoffmann-La Roche Ltd.
17.8. Hologic, Inc.
17.9. OraSure Technologies, Inc.
17.10. Siemens Healthineers AG

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2026
FIGURE 7. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (%)
FIGURE 12. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2026
FIGURE 14. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2026 (USD MILLION)
FIGURE 15. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 16. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTS, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 21. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2026
FIGURE 23. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 24. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 25. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRIVATE DIAGNOSTICS LABORATORIES, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRIVATE DIAGNOSTICS LABORATORIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 30. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 31. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRIVATE DIAGNOSTICS LABORATORIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: SCORES
TABLE 16. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 17. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 18. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: RANKING
TABLE 19. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 20. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 21. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 22. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 23. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 24. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 25. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Alere Inc.
Becton Dickinson and Company
Bio-Rad Laboratories, Inc.
Chembio Diagnostic Systems Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
OraSure Technologies, Inc.
Siemens Healthineers AG